Affimed (AFMD) EBITDA margin US GAAP (year values) |
|||||||||
| 2021 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -158.6% | -158.6% | -209.5% | -197.0% | -1 237% | -7 472% | ||
| Changes by years, y/y, % | -38pp | 0pp | -51pp | +12pp | -1 040pp | +73.1% | |||
Affimed. EBITDA margin, %
Affimed. EBITDA margin, changes, pp
Affimed (AFMD) EBITDA margin US GAAP (quarter values) |
||||||||
| 2024Q1 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | -10 788% | -4 677% | -11 010% | -9 547% | -9 320% | -7 472% | |
| Changes by years, y/y, % | -4 428pp | -7 478pp | -8 119pp | |||||
| Changes by quarters, q/q, % | -9 587pp | +6 111pp | -6 332pp | +1 463pp | +227pp | |||